文献速递肝病

饮酒对非酒精性脂肪性肝病患者生存的影响:一项全国前瞻性队列研究

Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
PubMed 文献 · Hepatology · 2018-10-02

该研究基于1988至2010年美国国家健康与营养调查参与者数据,链接国家死亡指数随访生存,以肝脂肪变性指数诊断非酒精性脂肪性肝病,纳入4568例患者,采用多因素Cox比例风险模型分析饮酒对生存的影响。结果显示每日饮酒0.5-1.5杯与全因死亡风险降低相关,而每日饮酒≥1.5杯与死亡风险增加相关。

要点

  • 每日饮酒0.5-1.5杯与不饮酒相比,全因死亡风险降低41%(HR=0.59)。
  • 每日饮酒≥1.5杯在进一步校正后与死亡风险增加相关(HR=1.45)。
  • 该研究结果有助于讨论非酒精性脂肪性肝病患者饮酒的潜在风险与获益。

核心结论

  • 在非酒精性脂肪性肝病患者中,适度饮酒与全因死亡率显著降低相关,而每日饮酒≥1.5杯与死亡率增加相关。

研究设计与样本

  • 研究纳入1988至2010年美国国家健康与营养调查中4568例经肝脂肪变性指数诊断的非酒精性脂肪性肝病患者,并链接国家死亡指数进行随访。

主要发现

  • 在仅校正年龄、性别和吸烟史的模型中,每日饮酒0.5-1.5杯与不饮酒相比,全因死亡风险降低41%(HR=0.59,95%CI 0.40-0.85,P=0.005)。
  • 在仅校正年龄、性别和吸烟史的模型中,每日饮酒≥1.5杯与不饮酒相比,全因死亡风险呈危害趋势(HR=1.16,95%CI 0.99-1.36,P=0.119)。
  • 进一步校正种族、体力活动、教育水平、糖尿病及纤维和多不饱和脂肪酸摄入后,每日饮酒0.5-1.5杯仍显示显著保护作用(HR=0.64,95%CI 0.42-0.97,P=0.035)。
  • 进一步校正后,每日饮酒≥1.5杯显示对死亡率有显著危害作用(HR=1.45,95%CI 1.01-2.10,P=0.047)。

临床怎么用

  • 作者认为,该研究结果有助于讨论非酒精性脂肪性肝病患者饮酒的潜在风险与获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) comprises more than two thirds of patients with chronic liver disease in the United States. The effect of alcohol consumption on survival in patients with NAFLD is not clear. We gathered data on National Health and Nutrition Examination Survey participants from 1988 to 2010, and linked them to the National Death Index for follow-up of their survival. We diagnosed NAFLD based on a previously validated biochemical model (Hepatic Steatosis Index). We built multivariate Cox proportional hazards models to evaluate the effect of alcohol consumption on survival of patients with NAFLD. After excluding participants with significant alcohol use, viral hepatitis, or increased transferrin saturation, 4,568 participants with NAFLD were included in the analysis. In a Cox model adjusted for age, sex, and smoking history, drinking 0.5-1.5 drinks per day decreased the risk of overall mortality by 41% (hazard ratio [HR] = 0.59, 95% confidence interval [CI] 0.40-0.85, P = 0.005) compared with not drinking. Drinking ≥1.5 drinks per day showed a trend toward harm (HR = 1.16, 95% CI 0.99-1.36, P = 0.119). After further adjustment for race, physical activity, education level, diabetes, and fiber and polyunsaturated fatty acid intake, drinking 0.5-1.5 drinks per day continued to show a significant protective effect (HR = 0.64, 95% CI 0.42-0.97, P = 0.035), and drinking ≥1.5 drinks per day showed a significant harmful effect on mortality (HR = 1.45, 95% CI 1.01-2.10, P = 0.047). Among patients with NAFLD, modest alcohol consumption is associated with a significant decrease in all-cause mortality, whereas drinking ≥1.5 drinks per day is associated with an increase in mortality. These results help to inform the discussion of potential risks and benefits of alcohol use in patients with NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hajifathalian K, Torabi Sagvand B, McCullough AJ, et al. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study. Hepatology. 2018. PMID: 30125379. doi:10.1002/hep.30226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。